Innovative forms of therapy for complex bowel diseases: Takeda wins German Brand Award
Innovative forms of therapy for complex bowel diseases: Takeda wins German Brand Award
The company Takeda has been committed to people with complex bowel diseases such as chronic inflammatory bowel diseases (CED), short intestine syndrome (KDS) and perianal fistulas. Through their continuous research and development, Takeda is able to offer the affected people innovative forms of therapy in order to facilitate life with the disease. In addition, Takeda is committed to creating education and awareness of patients with a complex bowel disease in public. For this reason, Takeda launched the campaign "Despite the complex bowel disease", which has now been awarded the German Brand Award in the "Excellence in Brand Strategy and Creation: Brand Communication - 360 ° Campaign" category.
The Takeda campaign aimed to discover the topic of intestinal diseases and to create more visibility for those affected. In order to achieve this, the company set specifically in places where people linger, such as public transport, restaurants or airports. There, people were confronted with unpleasant topics and situations that are commonplace for people with complex bowel diseases. By confronting the public with these tabooed symptoms such as diarrhea, flatulence or purulent discharge, Takeda should be awakened by people's empathy. Through the campaign, Takeda wanted to reduce the suffering of those affected and contribute to horror. A special challenge is that the complex bowel diseases are often not visible from the outside. With her campaign, Takeda makes these invisible diseases visible.
In order to involve the perspective of those affected themselves, three people were selected as part of the campaign who shared their personal experiences for the complex bowel diseases CED, KDS and perianal fistulas. In addition, poster campaigns in regional transport in Hamburg and Berlin, in health media and on social media were carried out.
Takeda is a leading biopharmaceutical company with its headquarters in Japan and is committed to improving people and enabling a better future. Her core areas include gastroenterological and inflammatory diseases, rare diseases, plasma -based therapies, oncology, neurosciences and vaccines. The company is working in partnerships to improve the quality of life of the patients and create new treatment options.
The award with the German Brand Award shows the tribulation of the Takeda campaign and underlines the importance of education and visibility in connection with complex bowel diseases. Such campaigns can strengthen awareness and understanding in society to facilitate the life of those affected.
The following table shows a summary of the information:
| Company | Takeda |
| Campaign | Enjoy unique moments - despite the complex bowel disease |
| Award | German Brand Award in the "Excellence on Brand Strategy and Creation: Brand Communication - 360 ° Campaign" |
| Goal of the campaign | Create dutialization and visibility of complex bowel diseases |
| Implementation of the campaign | Poster campaigns in regional transport, health media and social media |
| Meaning of the award | Recognition of the efforts to clarify and visibility of bowel diseases |
The Takeda campaign shows how important it is to create education and visibility for complex bowel diseases. Through such measures, understanding and empathy in society can be strengthened in order to facilitate life with their illness.